- Company info
- News & events
- Investors
- Contacts & help
News archive for 2003
Find below ReNeuron's archived press releases for 2003
ReNeuron presents brain stem cell data at London conference. 24/09/03
ReNeuron's Chief Scientific Officer, Dr John Sinden, today provided an update on the Company's stem cell transplantation programmes at the Marcus …
Read articleReNeuron announces Board changes. 24/09/03
Following its recent acquisition by St James MGP Limited, ReNeuron Holdings PLC has now completed its re-registration as a private company under its …
ReNeuron to Present ReN1820 data at Major Interstitial Cystitis Symposium. 22/08/03
ReNeuron will present strongly positive pre-clinical efficacy data on its soluble receptor, ReN1820, at the ‘Research Insights into Interstitial …
ReNeuron welcomes advance in UK academic stem cell research. 13/08/03
ReNeuron welcomes today's announcement that a research team at Kings College London have been successful in growing the UK's first human embryonic …
ReNeuron Solves Stem Cell Stability Problem. 29/07/03
ReNeuron has received confirmation that its immortalised, human, neural stem cells are genetically stable in long-term culture. Long-term genotypic …
Cancellation of listing on AIM. 08/05/03
KPMG Corporate Finance, on behalf of St James's MGP Limited ("St James's"), announced on 6th May 2003 that the Offer for ReNeuron has become wholly …
St. James's MGP Ltd Offer Update. 06/05/03
Not for release, publication or distribution in, into or from the United States, Canada, Australia or Japan RECOMMENDED CASH OFFER by KPMG Corporate …
St. James's MGP Ltd Offer Update. 01/05/03
Not for release, publication or distribution in, into or from the United States, Canada, Australia or Japan RECOMMENDED CASH OFFER by KPMG Corporate …
Result of EGM. 29/04/03
ReNeuron Holdings plc (the "Company") Result of EGM The Company announces that at today's extraordinary general meeting the ordinary resolution …
ReNeuron's ReNcell product presented at British Neuroscience Association conference. 15/04/03
ReNeuron scientists (1) today presented recent data on ReNcell, the Company's human neural stem cell lines for use in drug discovery. ReNeuron is …
ReNeuron's research programme not affected by European Parliament vote on stem cell research. 11/04/03
ReNeuron has noted yesterday's vote by MEPs against the use of embryonic stem cells (ESC's) in research and for special rules for the use of human …
Mr Paul Fellerman Rule 8 - ReNeuron Hldgs PLC. 10/04/03
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing - 09/04/03 Dealing in RENEURON HOLDINGS …
Recommended Cash Offer for ReNeuron Holdings plc ("ReNeuron"). 08/04/03
In connection with the Offer, being made by KPMG Corporate Finance on behalf of St. James's MGP Limited ("St. James's"), the board of St James's …
WestLB Panmure Ltd EMM Disclosure. 01/04/03
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED …
Recommended Cash Offer for ReNeuron Holdings plc (. 01/04/03
RECOMMENDED CASH OFFER at 10 pence per share by KPMG Corporate Finance on behalf of St. James's MGP Limited ("St. James's") for ReNeuron Holdings plc …
ReNeuron Holdings plc ("ReNeuron" or the "Company") Statement re possible offer. 17/02/03
The Board of ReNeuron has noted the recent press speculation concerning the possibility of a sale of the Company. The Board confirms that it has …
Top of page